angiotensin ii has been researched along with adenosine in 147 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (34.01) | 18.7374 |
| 1990's | 41 (27.89) | 18.2507 |
| 2000's | 39 (26.53) | 29.6817 |
| 2010's | 13 (8.84) | 24.3611 |
| 2020's | 4 (2.72) | 2.80 |
| Authors | Studies |
|---|---|
| Abboud, FM; Heistad, DD; Mark, AL; Schmid, PG | 1 |
| Kokubu, T; Nagasaka, Y; Nishimura, K; Ueda, E; Yamamura, Y | 1 |
| Osswald, H; Spielman, WS | 2 |
| Nakanishi, H; Ohtaki, Y; Ueda, J | 1 |
| Hookway, BW; McMurtry, IF; Roos, SD | 1 |
| Hookway, BW; McMurtry, IF; Roos, S | 1 |
| Hintze, TH; Kaley, G | 1 |
| Heidenreich, O; Osswald, H; Schmitz, HJ | 1 |
| Abe, K; Abe, T | 1 |
| Delarue, C; Fasolo, A; Feuilloley, M; Geymonat, M; Vaudry, H; Yon, L | 1 |
| Salvetti, A; Taddei, S | 1 |
| Holycross, BJ; Jackson, EK | 2 |
| Churchill, PC; Ellis, VR | 1 |
| Favilla, S; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Bottiglieri, DF; Jackson, EK; Kost, CK | 1 |
| Jackson, EK; Kost, CK | 1 |
| Favilla, S; Mattei, P; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Briggs, JP; Lorenz, JN; Schnermann, J; Weihprecht, H | 2 |
| Churchill, PC; Ellis, VR; Rossi, NF | 1 |
| Dietrich, MS; Endlich, K; Parekh, N; Steinhausen, M | 1 |
| Heller, LJ; Trachte, GJ | 1 |
| Branch, RA; Deray, G; Herzer, WA; Jackson, EK; Sabra, R | 1 |
| Endlich, K; Steinhausen, M; Wiegman, DL | 1 |
| Shepherd, JT; Vanhoutte, PM | 2 |
| Blank, D; Eccleston-Joyner, CA; Gilmore, JP; Joyner, WL; Young, R | 1 |
| Steinhausen, M | 1 |
| Lagerkranser, M; Sollevi, A; Stånge, K | 1 |
| Fain, JN; Lee, HM | 1 |
| Holycross, BJ; Jackson, EK; Li, P | 1 |
| Hackenthal, E; Taugner, R | 1 |
| Johnston, CI; Leung, E; Woodcock, EA | 2 |
| Gilmore, JP; Joyner, WL; Myers, TO | 1 |
| Amundsen, SM; Faraci, FM; Heistad, DD; Mayhan, WG | 1 |
| Bian, K; Inoue, S; Toda, N | 1 |
| Creek, RD; Katholi, RE; McCann, WP | 1 |
| Landauer, M; Phernetton, TM; Rankin, JH | 1 |
| Granger, JP; Hall, JE | 2 |
| Kaiser, L; Sparks, HV | 1 |
| Granger, JP; Hall, JE; Hester, RL | 1 |
| García-Iglesias, C; López-Novoa, JM; Macias-Nuñez, JF; Santos, JC; Sanz, E | 1 |
| Johnson, AR; Mayer, SE; Moran, NC | 1 |
| Cohen, MV; Kirk, ES | 1 |
| Bell, C | 1 |
| Collier, JG | 1 |
| Hatanaka, Y; Ito, T; Kokubu, T; Ueda, E; Yamamura, Y | 1 |
| Douglas, JR; Minkes, MS; Needleman, P | 1 |
| Juan, H; Lembeck, F | 1 |
| Spielman, WS | 1 |
| Weiner, N | 1 |
| Hackenthal, E; Schwertschlag, U; Taugner, R | 1 |
| Linden, J; Sperelakis, N; Vogel, S | 1 |
| Eikenburg, DC; Lokhandwala, MF | 1 |
| Juhász-Nagy, A; Miklós, ES | 1 |
| Funahara, Y; Hirata, M; Kitaguchi, H; Miki, M; Ogawa, K | 1 |
| Cornish, KG; Gilmore, JP; Joyner, WL | 1 |
| Bell, PD; Navar, LG | 1 |
| Branch, RA; Gerkens, JF; Heidemann, HT; Jackson, EK | 1 |
| Hermes, HH; Nabakowski, G; Osswald, H | 1 |
| Ohtaki, Y; Ueda, J | 1 |
| Azuma, T; Ohhashi, T | 1 |
| Heidenreich, S; Hirsch, J; Kleta, R; Schlatter, E; Schlüter, H; Zidek, W | 1 |
| Bassenge, E; Busse, R; Hecker, M; Pörsti, I | 1 |
| Armour, JA; Huang, MH; Wolf, SG | 1 |
| Cano, C; Malik, KU; Slavik, KJ | 1 |
| Endoh, M | 1 |
| Lin, HC; Tseng, CJ; Tung, CS; Wan, FJ | 1 |
| Angus, JA; Jennings, G; Kaye, DM | 1 |
| Jackson, EK; Munger, KA | 1 |
| Carruthers, AM; Fozard, JR | 2 |
| Besse, T; Chatzopoulos, C; Fishbein, J; Gianello, P; Gustin, T; Ketelslegers, JM; Lambotte, L; Squifflet, JP | 1 |
| Barrett, RJ; Droppleman, DA | 1 |
| Hara, S; Matsumura, M; Ueda, M | 1 |
| Carmines, PK; Inscho, EW | 1 |
| Cox, BF; Kitzen, JM; Perrone, MH; Smits, GJ | 1 |
| Briggs, JP; He, XR; Lorenz, JN; Schnermann, J; Skøtt, O; Weihprecht, H | 1 |
| Guignard, JP; Huet, F; John, E; Semama, D | 1 |
| Cermak, R; Forssmann, WG; Kleta, R; Schlatter, E | 1 |
| Kreisberg, MS; Pallone, TL; Silldorff, EP | 1 |
| Kurz, T; Münch, G; Richardt, G; Seyfarth, M; Urlbauer, T | 1 |
| Barclay, KD; Klassen, GA; Paton, B; Wong, AY; Wong, R | 1 |
| Oberlies, NH; Packer, CS; Rhoades, RA; Roepke, JE | 1 |
| Berthold, H; Ehmke, H; Just, A; Kirchheim, HR; Osswald, H | 1 |
| Abe, Y; Aki, Y; Tamaki, T | 1 |
| Duranti, P; Favilla, S; Ghiadoni, L; Marraccini, P; Marzilli, M; Orsini, E; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Georgiev, V; Kambourova, T; Tchekalarova, J | 4 |
| Russell, A; Watts, S | 1 |
| Andersson, A; Carlsson, PO; Jansson, L; Olsson, R | 1 |
| Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
| Guimarães, S; Mota, A; Moura, D; Paiva, MQ | 1 |
| Herzer, WA; Jackson, EK; Mi, Z; Swamy, RS | 1 |
| Pallone, TL; Silldorff, EP | 1 |
| Armour, JA; Chen, RP; Thompson, GW | 1 |
| Arntz, E; Boemke, W; Höhne, C; Kaczmarczyk, G; Krebs, MO | 1 |
| Kawamura, M; Masaki, E; Niitsu, A; Nishi, H | 1 |
| Kvist, S; Mulvany, MJ | 1 |
| Gouyon, JB; Guignard, JP; Huet, F; Prévot, A; Semama, DS | 1 |
| Abe, Y; Aki, Y; Kimura, S; Kohno, M; Miyatake, A; Nishiyama, A | 1 |
| Hein, TW; Kuo, L; Wang, W; Zhang, C | 1 |
| Goldenberg, I; Grossman, E; Jacobson, KA; Shainberg, A; Shneyvays, V | 1 |
| Caruso-Neves, C; Gomes, CP; Leão-Ferreira, LR; Lopes, AG | 1 |
| Cook, AK; Edwards, B; Field, M; Imig, JD; Inscho, EW; Pollock, JS; Zhang, S; Zhang, Z; Zhao, X | 1 |
| Brown, R; Fredholm, BB; Lai, EY; Mrowka, R; Patzak, A; Persson, AE; Persson, PB; Spielmann, N; Steege, A | 1 |
| Bagi, Z; Hamar, P; Kardos, M; Koller, A | 1 |
| Fähling, M; Gericke, A; Lai, EY; Martinka, P; Mrowka, R; Patzak, A; Persson, AE; Persson, PB; Sendeski, M; Steege, A | 1 |
| Anrather, J; Girouard, H; Iadecola, C; Park, L; Zhou, P | 1 |
| Barreto-Chaves, ML; Fürstenau, CR; Sarkis, JJ; Trentin, DS | 1 |
| Fähling, M; Lai, EY; Martinka, P; Patzak, A; Persson, AE; Persson, PB; Sendeski, M | 1 |
| Bautista, R; Franco, M; González, L; Martínez, F; Monreal, R; Pacheco, U; Pérez-Méndez, O; Sánchez-Lozada, LG; Santamaría, J; Tapia, E | 1 |
| Capone, C; Girouard, H; Iadecola, C; Lessard, A; Milner, TA | 1 |
| Fähling, M; Gaestel, M; Jankowski, J; Jankowski, V; Lai, EY; Martinka, P; Patzak, A; Persson, AE; Persson, PB; Schubert, R | 1 |
| Laske-Ernst, J; Quast, U; Russ, U; Stehle, A; Vallon, V | 1 |
| Carlström, M; Eriksson, UJ; Lai, EY; Ma, Z; Patzak, A; Persson, AE; Sendeski, M; Steege, A; Zabihi, S | 1 |
| Briggs, JP; Schnermann, J | 1 |
| Caruso-Neves, C; Gomes, CP; Gomes-Quintana, E; Leão-Ferreira, LR; Lopes, AG; Pinheiro, AA; Wengert, M | 1 |
| Brown, RD; Carlström, M; Lai, EY; Ma, Z; Patzak, A; Persson, AE | 1 |
| Franco, M; Martínez, F; Pérez-Mendéz, O | 1 |
| Carlström, M; Lai, EY; Patzak, A; Persson, AE | 1 |
| Brunton, LL; Epperson, SA; Ramirez-Sanchez, I; Villarreal, F; Yamazaki, KG | 1 |
| Burke, SL; Evans, RG; Head, GA; Lambert, GW; Moretti, JL | 1 |
| Chen, H; McClure, JM; O'Leary, DS; Rossi, NF; Scislo, TJ | 1 |
| Angus, JA; Korner, PI; Wright, CE | 1 |
| Dahl, TD; Helle, F; Hultström, M; Iversen, BM | 1 |
| Hong, Z; Li, Z; Meininger, GA; Mesquitta, WT; Sun, Z; Trzeciakowski, JP | 1 |
| Fang, X; Huang, DN; Huang, XL; Tan, JX; Wang, B | 1 |
| Blackburn, MR; Colgan, SP; Dai, Y; Eltzschig, HK; Glover, L; Grenz, A; Kellems, RE; Luo, R; Ning, C; Sun, H; Sun, K; Tao, L; Wang, W; Xia, Y; Zhang, W; Zhang, Y | 1 |
| Atchison, DK; Beierwaltes, WH; Harding, P; Lasley, RD; Ortiz-Capisano, MC | 1 |
| Croy, BA; Leonard, S; Lima, PD; Murrant, CL | 1 |
| Bunyak, F; Ersoy, I; Hill, MA; Hong, Z; Jin, M; Li, M; Li, Z; Martinez-Lemus, L; Meininger, GA; Palaniappan, K; Staiculescu, MC; Sun, Z; Trzeciakowski, JP | 1 |
| Carlström, M; Gao, X; Patzak, A; Peleli, M; Persson, AE; Zollbrecht, C | 1 |
| Mustafa, SJ; Nayeem, MA; Tilley, SL; Yadav, VR | 1 |
| Böhm, M; Devaux, Y; Fries, P; Kazakov, A; Maack, C; Müller, A; Puhl, SL; Wagner, DR | 1 |
| Hirano, K; Igarashi, J; Karita, S; Kubota, Y; Nakai, K; Tsukamoto, I | 1 |
| Gao, R; Ge, W; Li, B; Wang, J; Zhang, W; Zhu, H | 1 |
| Cui, SX; Doviak, H; Epstein, FH; French, BA; Leor, J; Sano, S; Shah, SA; Walsh, K; Wang, Y; Waters, CD | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Cheng, XS; Lu, P; Peng, XG; Sheng, ZY; Wu, QH; Wu, YQ; Xu, Y; Zhang, JJ; Zhu, K | 1 |
| Becker, K; Bouvain, P; Flögel, U; Grandoch, M; Ibrahim, F; Massold, T; Niemann, V; Schrader, J; Steckel, B; Stegbauer, J; Temme, S | 1 |
14 review(s) available for angiotensin ii and adenosine
| Article | Year |
|---|---|
[Mechanism of renin release and cellular action of angiotensin II].
Topics: Adenosine; Angiotensin II; Animals; Dinoprostone; Epoprostenol; Humans; Juxtaglomerular Apparatus; Muscle, Smooth, Vascular; Receptors, Angiotensin; Renin; Sodium; Vasoconstriction | 1992 |
The afferent arteriole--the target for macula densa-generated signals.
Topics: Adenosine; Angiotensin II; Animals; Arterioles; Kidney Tubules, Distal; Signal Transduction; Vasoconstriction | 1991 |
Local modulation of adrenergic neurotransmission in blood vessels.
Topics: Acetylcholine; Acidosis; Adenosine; Angiotensin II; Animals; Blood Vessels; Cardiac Glycosides; Epinephrine; Histamine; Humans; Hypertension; Muscle, Smooth, Vascular; Neurotransmitter Agents; Norepinephrine; Potassium; Receptors, Adrenergic; Serotonin; Sympathetic Nervous System; Temperature | 1985 |
Hormonal signals and intracellular messengers for renin secretion.
Topics: Acetylcholine; Adenosine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Histamine; Hormones; Nerve Tissue Proteins; Neuropeptide Y; Norepinephrine; Platelet Activating Factor; Prostaglandins; Renin; Vasopressins | 1986 |
The role of cyclic nucleotides in the regulation of neurotransmitter release from adrenergic neurons by neuromodulators.
Topics: Acetylcholine; Adenosine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Calcium; Cyclic AMP; Dopamine; Enkephalins; Exocytosis; Histamine; Humans; Neurotransmitter Agents; Norepinephrine; Nucleotides, Cyclic; Oxidative Phosphorylation; Prostaglandins; Protein Kinases; Sympathetic Nervous System | 1980 |
George E. Brown memorial lecture. Local modulation of adrenergic neurotransmission.
Topics: Acetylcholine; Acidosis; Adenine Nucleotides; Adenosine; Angiotensin II; Animals; Dogs; Histamine; Humans; Muscle Contraction; Nerve Endings; Osmolar Concentration; Potassium; Receptors, Adrenergic, alpha; Serotonin; Sympathomimetics; Synaptic Transmission; Temperature; Vasodilation | 1981 |
Minireview. Presynaptic receptors and alterations in norepinephrine release in spontaneously hypertensive rats.
Topics: Adenosine; Angiotensin II; Animals; Blood Vessels; Calcium; Dinoprostone; Exocytosis; Hypertension; Norepinephrine; Prostaglandins E; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Purinergic; Sympathetic Nervous System; Synapses; Vascular Resistance; Vasoconstriction | 1983 |
Macula densa feedback control of glomerular filtration: role of cytosolic calcium.
Topics: Adenosine; Angiotensin II; Animals; Biological Transport; Blood Pressure; Calcimycin; Calcium; Capillaries; Cell Membrane Permeability; Cytosol; Feedback; Furosemide; Glomerular Filtration Rate; Hypotonic Solutions; Isotonic Solutions; Kidney Glomerulus; Kidney Tubules; Kidney Tubules, Distal; Muscle, Smooth, Vascular; Nephrons; Perfusion; Pressure; Prostaglandins; Sodium; Sodium Chloride | 1982 |
The effects of various drugs on the myocardial inotropic response.
Topics: Adenosine; Angiotensin II; Animals; Calcium; Cyclic AMP; Endothelins; Humans; Myocardial Contraction; Phosphatidylinositols; Receptors, Muscarinic | 1995 |
Acute renal failure.
Topics: Acute Disease; Acute Kidney Injury; Adenosine; Age Factors; Angiotensin II; Animals; Animals, Newborn; Blood Flow Velocity; Calcium Channels; Disease Models, Animal; Endothelins; Free Radicals; Glomerular Filtration Rate; Humans; Hypoxia; Infant, Newborn; Rabbits; Reactive Oxygen Species; Renal Circulation; Risk Factors | 1993 |
[Paracrine regulation of renal hemodynamics].
Topics: Adenosine; Angiotensin II; Animals; Hemodynamics; Kidney; Nitric Oxide; Paracrine Communication; Rabbits; Receptors, Vasopressin; Vasopressins | 1998 |
Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice.
Topics: Adenosine; Adenosine Triphosphatases; Angiotensin II; Animals; Feedback, Physiological; Kidney Glomerulus; Kidney Tubules; Mice; Mice, Transgenic | 2008 |
Interaction of intrarenal adenosine and angiotensin II in kidney vascular resistance.
Topics: Adenosine; Angiotensin II; Animals; Humans; Kidney; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Renal Circulation; Sodium Chloride; Vascular Resistance | 2009 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
2 trial(s) available for angiotensin ii and adenosine
| Article | Year |
|---|---|
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension.
Topics: Acetylcholine; Adenosine; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiac Catheterization; Coronary Circulation; Dose-Response Relationship, Drug; Female; Forearm; Hemodynamics; Humans; Hypertension; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Nitroprusside; Renin; Renin-Angiotensin System | 1999 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
132 other study(ies) available for angiotensin ii and adenosine
| Article | Year |
|---|---|
Effect of hypoxemia on responses to norepinephrine and angiotensin in coronary and muscular vessels.
Topics: Adenosine; Angiotensin II; Animals; Blood Pressure; Carbon Dioxide; Coronary Vessels; Dogs; Hydrogen-Ion Concentration; Hypoxia; Indomethacin; Muscles; Norepinephrine; Oxygen; Prostaglandins E; Prostaglandins F; Regional Blood Flow | 1975 |
Metabolism of vasoactive substances in the lung: Change of metabolism and its significance in rabbits with experimental pneumonitis.
Topics: Adenosine; Angiotensin II; Animals; Bradykinin; Carboxypeptidases; Hydrogen-Ion Concentration; In Vitro Techniques; Lung; Pneumonia; Prostaglandins E; Rabbits | 1975 |
Blockade of postocclusive renal vasoconstriction by an angiotensin II antagonists: evidence for an angiotensin-adenosine interaction.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adenosine; Angiotensin II; Animals; Dogs; Kidney; Norepinephrine; Regional Blood Flow; Renal Artery Obstruction; Vasoconstriction | 1979 |
[Effects of adenosine compounds of the vascular bed and effects of dilazep, theophylline, and indomethacin on blood flow changes of the postocclusive renal vessels].
Topics: Adenine Nucleotides; Adenosine; Angiotensin II; Animals; Azepines; Blood Flow Velocity; Blood Vessels; Dilazep; Dogs; Drug Synergism; Female; Femoral Artery; Indomethacin; Kidney; Ligation; Male; Mesenteric Arteries; Norepinephrine; Renal Artery; Theophylline | 1977 |
Red blood cells but not platelets prolong vascular reactivity of isolated rat lungs.
Topics: Adenosine; Angiotensin II; Animals; Blood Platelets; Blood Pressure; Erythrocytes; Glucose; In Vitro Techniques; Male; Meclofenamic Acid; Oxygen; Perfusion; Pulmonary Circulation; Rats; Time Factors | 1978 |
Characterization of the postocclusive response of renal blood flow in the cat.
Topics: Adenosine; Angiotensin II; Animals; Blood Flow Velocity; Cats; Indomethacin; Ischemia; Kidney; Meclofenamic Acid; Phenoxybenzamine; Phentolamine; Prostaglandins; Renal Artery Obstruction; Vasoconstriction | 1978 |
Red blood cells play a crucial role in maintaining vascular reactivity to hypoxia in isolated rat lungs.
Topics: Adenosine; Angiotensin II; Animals; Blood Platelets; Erythrocytes; Glucose; Hypoxia; Lung; Meclofenamic Acid; Rats; Stimulation, Chemical; Vasomotor System | 1977 |
Prostaglandins and the control of blood flow in the canine myocardium.
Topics: Adenosine; Angiotensin II; Animals; Arachidonic Acids; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Heart Rate; Hyperemia; Hypoxia; Indomethacin; Male; Meclofenamic Acid; Prostaglandin Antagonists; Prostaglandins; Prostaglandins E | 1977 |
Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia.
Topics: Adenosine; Adenosine Monophosphate; Angiotensin II; Animals; Blood Flow Velocity; Blood Pressure; Glomerular Filtration Rate; Hemorrhage; Kidney; Male; Rats; Renin; Sodium | 1975 |
In vitro study of the effect of adenosine on frog adrenocortical cells.
Topics: Adenosine; Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; In Vitro Techniques; Kidney; Male; Perfusion; Phenylisopropyladenosine; Radioimmunoassay; Rana ridibunda; Vasoactive Intestinal Peptide | 1992 |
Vascular tissue renin-angiotensin system in hypertensive humans.
Topics: Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Vessels; Forearm; Humans; Hypertension; Isoproterenol; Norepinephrine; Receptors, Adrenergic, beta; Renin; Renin-Angiotensin System; Saralasin | 1992 |
Effects of chronic treatment with caffeine on kidney responses to angiotensin II.
Topics: Adenosine; Angiotensin II; Animals; Caffeine; Drug Administration Schedule; Glomerular Filtration Rate; Kidney; Kidney Function Tests; Male; Perfusion; Rats; Rats, Sprague-Dawley | 1992 |
Dantrolene stimulates renin secretion by rat renal cortical slices but fails to block calcium-dependent inhibition.
Topics: Adenosine; Angiotensin II; Animals; Calcium; Dantrolene; Intracellular Fluid; Kidney Cortex; Male; Ouabain; Potassium; Rats; Rats, Inbred Strains; Renin; Stimulation, Chemical; Time Factors; Vasopressins | 1992 |
Adenosine activates a vascular renin-angiotensin system in hypertensive subjects.
Topics: Adenosine; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Blood Vessels; Captopril; Female; Forearm; Humans; Male; Middle Aged; Renin-Angiotensin System; Theophylline | 1992 |
Angiotensin II-induced [3H]adenosine release from in situ rat lung.
Topics: Adenosine; Anesthesia; Angiotensin II; Animals; Chromatography, Thin Layer; Hypertension; Lung; Male; Nephrectomy; Pulmonary Circulation; Rats; Rats, Inbred Strains; Renin; Saralasin | 1990 |
Effect of angiotensin II on plasma adenosine concentrations in the rat.
Topics: Adenosine; Anesthesia; Angiotensin II; Animals; Consciousness; Dose-Response Relationship, Drug; Hypertension; Infusions, Intravenous; Injections, Intraperitoneal; Kidney; Lung; Male; Rats; Rats, Inbred Strains; Renin | 1991 |
Adenosine causes angiotensin II release in human forearm arterioles.
Topics: Adenosine; Adult; Angiotensin II; Arteries; Arterioles; Blood Volume; Dose-Response Relationship, Drug; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Veins | 1991 |
Calcium-dependent inhibition of renin secretion: TMB-8 is a non-specific antagonist.
Topics: Adenosine; Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Gallic Acid; Kidney Cortex; Male; Methoxamine; Potassium; Rats; Rats, Inbred Strains; Renin; Vasopressins | 1991 |
Interaction between adenosine and angiotensin II in renal microcirculation.
Topics: Adenosine; Angiotensin II; Animals; Drug Interactions; Female; Kidney Glomerulus; Microcirculation; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Saralasin; Vasoconstriction; Xanthines | 1991 |
Adenosine receptor antagonism attenuates angiotensin II effects on adrenergic neurotransmission in the rabbit isolated vas deferens.
Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Norepinephrine; Purinergic Antagonists; Rabbits; Receptors, Adrenergic; Receptors, Purinergic; Synaptic Transmission; Theophylline; Vas Deferens | 1990 |
Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dog.
Topics: Adenosine; Angiotensin II; Animals; Captopril; Dogs; Kidney; Renal Circulation; Saline Solution, Hypertonic; Theophylline; Vasoconstriction | 1990 |
Glomerular blood flow.
Topics: Adenosine; Angiotensin II; Animals; Catecholamines; Glomerular Filtration Rate; Homeostasis; Humans; Kidney Glomerulus; Microcirculation; Regional Blood Flow | 1990 |
In vivo microscopy of the cerebral microcirculation using neonatal allografts in hamsters.
Topics: Adenosine; Angiotensin II; Animals; Animals, Newborn; Arterioles; Blood Vessels; Cerebral Cortex; Cerebrovascular Circulation; Cheek; Cricetinae; Dextrans; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Isoproterenol; Microcirculation; Nerve Tissue; Norepinephrine | 1988 |
[Current results on the hormonal and autoregulatory control of renal blood flow].
Topics: Adenosine; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium Channels; Homeostasis; Hydronephrosis; Kidney; Microcirculation; Muscle, Smooth, Vascular; Norepinephrine; Rats; Regional Blood Flow; Renal Circulation; Renin | 1989 |
Effect of adenosine-induced hypotension on the cerebral autoregulation in the anesthetized pig.
Topics: Adenosine; Anesthesia, Inhalation; Angiotensin II; Animals; Blood Pressure; Carbon Dioxide; Cardiac Catheterization; Catheterization; Cerebrovascular Circulation; Fentanyl; Homeostasis; Hypotension, Controlled; Nitrous Oxide; Oxygen; Swine; Vascular Resistance | 1989 |
Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
Topics: Adenosine; Analysis of Variance; Angiotensin II; Animals; Drug Synergism; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Synaptic Transmission; Vasoconstriction; Xanthines | 1989 |
Regulation of oxytocin-induced phosphoinositide breakdown in adipocytes by adenosine, isoproterenol and insulin.
Topics: Adenosine; Adenosine Deaminase; Adipose Tissue; Angiotensin II; Animals; Arginine Vasopressin; Cells, Cultured; Insulin; Isoproterenol; Kinetics; Male; Oxytocin; Phenylisopropyladenosine; Phosphatidylinositols; Rats; Rats, Inbred Strains; Vasotocin | 1989 |
Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
Topics: Adenosine; Aldosterone; Angiotensin II; Animals; Blood Pressure; Caffeine; Heart Rate; Male; Rats; Rats, Inbred Strains; Xanthines | 1989 |
Stimulation of phosphatidylinositol metabolism in the heart.
Topics: Adenosine; Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Membrane; Guinea Pigs; In Vitro Techniques; Myocardium; Parasympathomimetics; Phosphatidylinositols; Vasopressins | 1986 |
Angiotensin reactivity in the cheek pouch of the renovascular hypertensive hamster.
Topics: Adenosine; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cricetinae; Dose-Response Relationship, Drug; Female; Hypertension, Renovascular; Microcirculation | 1988 |
Responses of cerebral arteries after ischemia and reperfusion in cats.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Cats; Cerebral Arteries; Cerebrovascular Circulation; Ischemic Attack, Transient; Perfusion; Serotonin; Vasodilation | 1988 |
Age-related changes in the response to vasoconstrictor and dilator agents in isolated beagle coronary arteries.
Topics: Acetylcholine; Adenosine; Aging; Angiotensin II; Animals; Coronary Vessels; Dogs; Epoprostenol; Female; Histamine; In Vitro Techniques; Male; Serotonin; Vasoconstrictor Agents; Vasodilator Agents | 1987 |
Endogenous intrarenal adenosine preserves renal blood flow in one-kidney, one clip rats.
Topics: Adenosine; Angiotensin II; Animals; Atenolol; Blood Pressure; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Renal Circulation; Saralasin; Theophylline; Vascular Resistance | 1988 |
Maternal ovine placental vascular responses to adenosine.
Topics: Adenosine; Angiotensin II; Animals; Blood Pressure; Female; Microspheres; Placenta; Pregnancy; Pregnancy, Animal; Radioisotopes; Regional Blood Flow; Sheep; Vascular Resistance; Vasodilator Agents | 1986 |
Adenosine alters glomerular filtration control by angiotensin II.
Topics: Adenosine; Angiotensin II; Animals; Dogs; Drug Interactions; Glomerular Filtration Rate; Injections; Kidney; Male | 1986 |
Stimulation of phosphatidylinositol metabolism in atrial and ventricular myocytes.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Carbachol; Guinea Pigs; Heart Atria; Heart Ventricles; Inositol Phosphates; Lithium; Muscle, Smooth, Vascular; Oxotremorine; Phosphatidylinositols; Time Factors; Vasopressins | 1986 |
Endothelial cells. Not just a cellophane wrapper.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Blood Platelets; Bradykinin; Dogs; Endothelium; Humans; Prostaglandins; Serotonin; Vasodilation | 1987 |
Interactions between adenosine and angiotensin II in controlling glomerular filtration.
Topics: Adenosine; Angiotensin II; Animals; Captopril; Diuresis; Dogs; Drug Interactions; Glomerular Filtration Rate; Kidney Concentrating Ability; Kidney Glomerulus; Male; Renal Circulation; Renin-Angiotensin System; Vasoconstriction | 1985 |
Influence of plasma renin content, intrarenal angiotensin II, captopril, and calcium channel blockers on the vasoconstriction and renin release promoted by adenosine in the kidney.
Topics: Adenosine; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Captopril; Diet, Sodium-Restricted; Dogs; Extracellular Space; Female; Kidney; Male; Propranolol; Renal Circulation; Renin; Vasoconstriction; Verapamil | 1985 |
Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs.
Topics: Adenosine; Angiotensin II; Animals; Blood Pressure; Consciousness; Dogs; Glomerular Filtration Rate; Hemodynamics; Injections; Kidney; Male; Nephrectomy; Renal Circulation; Time Factors | 1986 |
Cyclic AMP content and histamine release in rat mast cells.
Topics: Adenosine; Angiotensin II; Animals; Bradykinin; Cell Separation; Cyclic AMP; DNA; Enzyme Activation; Glucagon; Histamine Release; Isoproterenol; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Papaverine; Phosphoric Diester Hydrolases; Prostaglandins; Protein Kinases; Rats; Tissue Extracts; Trichloroacetic Acid; Vasopressins | 1974 |
Differential response of large and small coronary arteries to nitroglycerin and angiotensin. Autoregulation and tachyphylaxis.
Topics: Adenosine; Angiotensin II; Animals; Arteries; Blood Pressure; Coronary Circulation; Coronary Vessels; Dilatation; Dogs; Ischemia; Nitroglycerin; Perfusion; Tachyphylaxis; Time Factors; Vascular Resistance | 1973 |
Vasoactive substances in the circulation of the pregnant dog during acute fetal ischemia.
Topics: Adenosine; Angiotensin II; Animals; Blood Physiological Phenomena; Dogs; Female; Fetus; Ischemia; Pregnancy; Uterus | 1973 |
Proceedings: New dialysis technique for the continuous measurement of the concentration of vasoactive hormones.
Topics: Adenosine; Angiotensin II; Animals; Blood Proteins; Bradykinin; Dialysis; Dogs; Methods; Norepinephrine; Oxytocin; Prostaglandins; Protein Binding; Serotonin | 1972 |
Metabolism of vasoactive substances in the lung.
Topics: 5-Hydroxytryptophan; Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Blood Pressure; Bradykinin; Epinephrine; In Vitro Techniques; Lung; Norepinephrine; Perfusion; Polynucleotides; Prostaglandins; Pulmonary Circulation; Rabbits; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1973 |
Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adipose Tissue; Angiotensin II; Animals; Biological Assay; Chickens; Epinephrine; Female; Indomethacin; Kidney; Liver; Lung; Myocardium; Perfusion; Prostaglandins; Rabbits; Rats; Spleen | 1974 |
Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear.
Topics: Acetylcholine; Action Potentials; Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Blood Pressure; Drug Synergism; Ear; Eledoisin; Epinephrine; Female; Histamine; In Vitro Techniques; Male; Oxytocin; Pain; Peptides; Potassium Chloride; Prostaglandins; Rabbits; Respiration; Sensory Receptor Cells; Serotonin; Substance P; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins; Venous Pressure | 1974 |
Antagonistic effect of theophylline on the adenosine-induced decreased in renin release.
Topics: Adenosine; Angiotensin II; Animals; Blood Pressure; Cyclic AMP; Dogs; Drug Interactions; Female; Glomerular Filtration Rate; Kidney; Kidney Cortex; Lymph; Male; Natriuresis; Regional Blood Flow; Renin; Theophylline | 1984 |
Cellular mechanisms of renin release.
Topics: Adenosine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Calcium; Histamine; In Vitro Techniques; Kidney; Male; Prostaglandins; Rats; Rats, Inbred Strains; Renin | 1983 |
Sensitivity of Ca-dependent slow action potentials to methacholine is induced by phosphodiesterase inhibitors in embryonic chick ventricles.
Topics: 1-Methyl-3-isobutylxanthine; Action Potentials; Adenosine; Angiotensin II; Animals; Calcium; Chick Embryo; Cyclic AMP; Heart; Heart Ventricles; Imidazoles; Methacholine Chloride; Methacholine Compounds; Myocardium; Phosphodiesterase Inhibitors; Xanthines | 1982 |
Calcium antagonist verapamil inhibits adenosine-induced renal vasoconstriction in the dog.
Topics: Adenosine; Angiotensin II; Animals; Calcium; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Hemodynamics; Ion Channels; Kidney; Male; Rabbits; Renal Circulation; Vasoconstriction; Verapamil | 1984 |
Prostacyclin release from the coronary vascular wall by vasoactive substances.
Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Bradykinin; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Epoprostenol; Histamine; Isoproterenol; Platelet Aggregation; Serotonin; Thrombin | 1984 |
Pharmacological responses of the microvasculature of transplanted cardiac tissue.
Topics: Acetylcholine; Adenosine; Angiotensin I; Angiotensin II; Animals; Coronary Circulation; Cricetinae; Female; Isoproterenol; Microcirculation; Models, Cardiovascular; Nitroglycerin; Norepinephrine; Vasodilation | 1982 |
Aminophylline inhibits renal vasoconstriction produced by intrarenal hypertonic saline.
Topics: Adenosine; Aminophylline; Angiotensin II; Animals; Dogs; Kidney; Kinetics; Regional Blood Flow; Vasoconstriction | 1983 |
Role of adenosine in signal transmission of tubuloglomerular feedback.
Topics: Adenine; Adenosine; Angiotensin II; Animals; Dipyridamole; Dogs; Feedback; Glomerular Filtration Rate; Hydrostatic Pressure; Kidney Glomerulus; Kidney Tubules; Vasoconstriction | 1982 |
[Effects of adenosine compounds on the contractile response of isolated canine blood vessels to various agonists (author's transl)].
Topics: Adenine Nucleotides; Adenosine; Angiotensin II; Animals; Barium; Calcium; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Female; In Vitro Techniques; Male; Mesenteric Arteries; Norepinephrine; Potassium; Vasoconstriction | 1980 |
Paradoxical relaxation of arterial strips induced by vasoconstrictive agents.
Topics: Adenosine; Angiotensin II; Animals; Bradykinin; Dogs; Dopamine; Dose-Response Relationship, Drug; Female; Femoral Artery; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Papaverine; Serotonin; Vasoconstrictor Agents; Verapamil | 1980 |
Effects of diadenosine polyphosphates, ATP and angiotensin II on membrane voltage and membrane conductances of rat mesangial cells.
Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Cell Line; Dinucleoside Phosphates; Glomerular Mesangium; Hypertension; Kinetics; Membrane Potentials; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1995 |
Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Coronary Vessels; Cyclooxygenase Inhibitors; Endothelium, Vascular; Heart; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Nitric Oxide Synthase; Oligopeptides; Organ Size; Quinolines; Rabbits; Receptors, Angiotensin; Vascular Resistance; Vasodilation | 1993 |
Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurones.
Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Arrhythmias, Cardiac; Autonomic Agents; Bethanechol; Bethanechol Compounds; Bradykinin; Dogs; Female; Glutamates; Heart; Isoproterenol; Male; Myocardial Contraction; Neurons; Nicotine; Peptides; Purines; Substance P; Vasoactive Intestinal Peptide | 1994 |
Loss of adenosine-induced negative inotropic effect in hyperexcited rabbit hearts: relationship to PKC.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Behavior, Animal; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Enzyme Activation; Heart Rate; Imidazoles; In Vitro Techniques; Losartan; Male; Myocardial Contraction; Naphthalenes; Norepinephrine; Perfusion; Phentolamine; Phorbol 12,13-Dibutyrate; Polycyclic Compounds; Propranolol; Protein Kinase C; Rabbits; Tetradecanoylphorbol Acetate; Tetrazoles | 1995 |
Adenosine and glutamate modulate the cardiovascular responses of angiotensins II and III in the area postrema of rats.
Topics: Adenosine; Angiotensin II; Angiotensin III; Animals; Blood Pressure; Brain; Cardiovascular System; Glutamic Acid; Heart Rate; Male; Rats; Rats, Sprague-Dawley | 1995 |
Evidence for impaired endothelium dependent vasodilation in experimental left ventricular dysfunction.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Autonomic Nerve Block; Doxorubicin; Hindlimb; Injections, Intra-Arterial; Ischemia; Models, Cardiovascular; Nitroprusside; Norepinephrine; Rabbits; Vasoconstriction; Vasodilation; Ventricular Dysfunction, Left | 1994 |
Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
Topics: Adenosine; Analysis of Variance; Angiotensin II; Animals; Arterioles; Biphenyl Compounds; Blood Pressure; Capillaries; Glomerular Filtration Rate; Hematocrit; Hemodynamics; Imidazoles; Kidney Glomerulus; Losartan; Models, Cardiovascular; Muscle, Smooth, Vascular; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Reference Values; Regional Blood Flow; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Vascular Resistance; Xanthines | 1994 |
The cardiovascular effects of selective adenosine A1 and A2 receptor agonists in the pithed rat: no role for glibenclamide-sensitive potassium channels.
Topics: Adenosine; Adrenergic alpha-Agonists; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Cardiovascular System; Cyclopentanes; Glyburide; Heart Rate; Male; Parasympatholytics; Phenethylamines; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Sensitivity and Specificity; Theophylline; Time Factors | 1993 |
Measurement of the vasoconstrictive substances endothelin, angiotensin II, and thromboxane B2 in cold storage solution can reveal previous renal ischemic insults.
Topics: Adenosine; Allopurinol; Angiotensin II; Animals; Cryopreservation; Endothelins; Glutathione; Humans; Hypertonic Solutions; Insulin; Ischemia; Kidney; Kidney Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Radioimmunoassay; Raffinose; Rats; Rats, Wistar; Thromboxane B2 | 1994 |
Synergistic effects of angiotensin and adenosine in the renal microvasculature.
Topics: Adenosine; Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Drug Synergism; In Vitro Techniques; Isoquinolines; Kidney; Male; Microcirculation; Muscle, Smooth, Vascular; Purinergic P1 Receptor Antagonists; Quinapril; Rabbits; Rats; Rats, Sprague-Dawley; Renal Circulation; Saralasin; Tetrahydroisoquinolines; Theophylline; Vasoconstriction | 1994 |
Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Topics: Adenine; Adenosine; Angiotensin II; Animals; Arginine; Arginine Vasopressin; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Regional Blood Flow; Renal Circulation; Serotonin; Tetrazoles; Thromboxane A2; Vascular Resistance; Vasoconstriction | 1993 |
Studies of cardiovascular responses to some endogenous pressor and hypotensive agents in conscious stroke-prone spontaneously hypertensive rats of different ages.
Topics: Acetylcholine; Adenosine; Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiovascular Agents; Cerebrovascular Disorders; Heart Rate; Hemodynamics; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1993 |
Renal arteriolar angiotensin responses during varied adenosine receptor activation.
Topics: Adenosine; Angiotensin II; Animals; Arterioles; Dose-Response Relationship, Drug; Enalaprilat; In Vitro Techniques; Juxtaglomerular Apparatus; Kidney Medulla; Male; Muscle, Smooth, Vascular; Nephrons; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Renal Circulation; Vasoconstriction; Xanthines | 1994 |
Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilation.
Topics: Adenosine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Nifedipine; Nitroglycerin; Rats; Rats, Sprague-Dawley; Tetrazoles; Vascular Resistance; Vasodilation | 1993 |
Effects of adenosine and angiotensin on macula densa-stimulated renin secretion.
Topics: Adenosine; Angiotensin II; Angiotensin III; Animals; Female; Juxtaglomerular Apparatus; Pentostatin; Rabbits; Renin; Xanthines | 1993 |
Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Angiotensin II; Animals; Blood Pressure; Decerebrate State; Dose-Response Relationship, Drug; Hypotension; Male; Phenylisopropyladenosine; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Stereoisomerism; Vasodilator Agents | 1993 |
Natriuretic peptides increase a K+ conductance in rat mesangial cells.
Topics: Adenosine; Angiotensin II; Animals; Atrial Natriuretic Factor; Brain Chemistry; Cells, Cultured; Cyclic GMP; Electric Conductivity; Glomerular Mesangium; Membrane Potentials; Muscle Proteins; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Inbred WKY; Vasodilator Agents | 1996 |
Adenosine modulates vasomotor tone in outer medullary descending vasa recta of the rat.
Topics: Adenosine; Angiotensin II; Animals; Female; Hemodynamics; Kidney Medulla; Muscle Tonus; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1996 |
Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia.
Topics: Adenosine; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Electric Stimulation; Heart Atria; Humans; Hypoxia; In Vitro Techniques; Myocardium; Norepinephrine; Receptors, Angiotensin; Receptors, Presynaptic; Tetrodotoxin; Vasoconstrictor Agents | 1996 |
Red cell flux during the cardiac cycle in the rabbit myocardial microcirculation.
Topics: Adenosine; Adrenergic beta-Agonists; Angiotensin II; Animals; Coronary Circulation; Diastole; Erythrocytes; Heart Ventricles; Isoproterenol; Laser-Doppler Flowmetry; Microcirculation; Rabbits; Regional Blood Flow; Systole; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Myosin isoform shifts and decreased reactivity in hypoxia-induced hypertensive pulmonary arterial muscle.
Topics: Adenosine; Angiotensin II; Animals; Dose-Response Relationship, Drug; Hypertension; Hypoxia; Male; Muscle, Smooth, Vascular; Myosins; Norepinephrine; Potassium; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Serotonin | 1998 |
Renal haemodynamic responses to exogenous and endogenous adenosine in conscious dogs.
Topics: Adenosine; Angiotensin II; Animals; Diet, Sodium-Restricted; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Male; Renal Circulation; Saline Solution, Hypertonic; Xanthines | 1998 |
Long-term theophylline treatment changes the effects of angiotensin II and adenosinergic agents on the seizure threshold.
Topics: Adenosine; Angiotensin II; Animals; Convulsants; Differential Threshold; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Purinergic P1 Receptor Antagonists; Seizures; Theophylline; Time Factors | 2000 |
Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse.
Topics: Acetylcholine; Adenosine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Aorta, Thoracic; Dinoprost; Dopamine; Endothelin-1; Endothelium, Vascular; Histamine; In Vitro Techniques; Isometric Contraction; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Sprague-Dawley; Serotonin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II, and nitric oxide inhibition.
Topics: Adenosine; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Enzyme Inhibitors; Hematocrit; Hyperglycemia; Infusions, Intravenous; Injections; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Inbred WF; Regional Blood Flow | 2000 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Lack of interaction between alpha(2)-autoreceptors and prejunctional receptors mediating a facilitatory effect on noradrenaline release.
Topics: Adenosine; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Dose-Response Relationship, Drug; Electric Stimulation; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Protein alpha Subunits, Gs; Heterotrimeric GTP-Binding Proteins; In Vitro Techniques; Isoproterenol; Male; Phenethylamines; Phenoxybenzamine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Angiotensin; Receptors, Purinergic P1; Secologanin Tryptamine Alkaloids; Signal Transduction; Type C Phospholipases | 2000 |
Local and systemic effects of peritoneal lavage with high concentrations of adenosine in rats.
Topics: Adenosine; Adenosine Monophosphate; Angiotensin II; Animals; Blood Pressure; Cardiovascular Agents; Heart Rate; Hypoxanthine; Inosine; Male; Microdialysis; Peritoneal Lavage; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Vasoconstrictor Agents; Xanthines | 2000 |
Adenosine signaling in outer medullary descending vasa recta.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angiotensin II; Animals; Calcimycin; Calcium; Colforsin; Cyclic AMP; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Female; Ionophores; Kidney Medulla; Kinetics; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Signal Transduction; Thromboxane A2; Vasodilation | 2001 |
Transduction capabilities of neonatal ventricular afferent neurons in vivo.
Topics: Action Potentials; Adenosine; Angiotensin II; Animals; Animals, Newborn; Apnea; Cardiovascular Physiological Phenomena; Chemoreceptor Cells; Female; Heart Ventricles; Male; Mechanoreceptors; Neurons, Afferent; Nodose Ganglion; Physical Stimulation; Sensory Receptor Cells; Signal Transduction; Swine; Ventricular Function | 2001 |
Evidence that the renin decrease during hypoxia is adenosine mediated in conscious dogs.
Topics: Acute Disease; Adenosine; Aldosterone; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Carbon Dioxide; Consciousness; Diet, Sodium-Restricted; Dogs; Female; Heart Rate; Hemodynamics; Hypoxia; Oxygen; Partial Pressure; Potassium; Purinergic P1 Receptor Antagonists; Renin; Renin-Angiotensin System; Theophylline | 2001 |
Interaction between angiotensin IV and adenosine A(1) receptor related drugs in passive avoidance conditioning in rats.
Topics: 2-Chloroadenosine; Adenosine; Angiotensin II; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraventricular; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline | 2001 |
Extracellular ATP potentiates steroidogenic effect of adrenocorticotropic hormone in bovine adrenocortical fasciculata cells.
Topics: Adenosine; Adenosine Triphosphate; Adrenocorticotropic Hormone; Angiotensin II; Animals; Cattle; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Space; Hydrocortisone; Vasoconstrictor Agents; Vasodilator Agents; Zona Fasciculata | 2001 |
Reduced medication and normalization of vascular structure, but continued hypertension in renovascular patients after revascularization.
Topics: Acetylcholine; Adenosine; Angioplasty, Balloon; Angiotensin II; Antihypertensive Agents; Arteries; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Hypertension, Renovascular; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Norepinephrine; Renal Artery; Renin; Treatment Outcome; Vascular Resistance | 2001 |
Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors.
Topics: Adenosine; Angiotensin II; Angiotensin III; Angiotensins; Animals; Brain; Convulsants; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Seizures; Xanthines | 2001 |
Interaction of angiotensin II and III with adenosine A(1) receptor-related drugs in passive avoidance conditioning in rats.
Topics: Adenosine; Angiotensin II; Angiotensin III; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intraventricular; Male; Memory; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline | 2002 |
Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit.
Topics: Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Gas Analysis; Hypoxia; Indoles; Inulin; Kidney Diseases; Kidney Function Tests; Male; Rabbits; Renal Circulation; Theophylline; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Topics: Adenosine; Angiotensin II; Animals; Diuretics; Dogs; Dose-Response Relationship, Drug; Female; Infusions, Intra-Arterial; Male; Norepinephrine; Receptors, Purinergic P1; Renal Circulation; Vasoconstriction; Xanthines | 2002 |
Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function.
Topics: Adenosine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Free Radical Scavengers; Imidazoles; In Vitro Techniques; Losartan; Microcirculation; NADPH Oxidases; Nitric Oxide; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Superoxides; Swine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Vasomotor System | 2003 |
Adenosine protects against angiotensin II-induced apoptosis in rat cardiocyte cultures.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A3 Receptor Agonists; Angiotensin II; Animals; Apoptosis; Calcium; Cells, Cultured; Heart; In Situ Nick-End Labeling; Myocardium; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A3 | 2003 |
Adenosine reverses the stimulatory effect of angiotensin II on the renal Na+-ATPase activity through the A2 receptor.
Topics: Adenosine; Adenosine Triphosphatases; Angiotensin II; Animals; Cation Transport Proteins; Cell Membrane; Kidney Tubules, Proximal; Receptors, Adenosine A2; Signal Transduction; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Arterioles; Blood Pressure; Calcium; Calcium Signaling; Homeostasis; Hypertension; Intracellular Membranes; Kidney; Male; Microcirculation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Purinergic P2; Receptors, Purinergic P2X; Uridine Triphosphate; Vasoconstriction | 2005 |
Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Angiotensin II; Animals; Arterioles; Feedback; Female; Kidney Glomerulus; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenethylamines; Purines; Receptor, Adenosine A1; Receptors, Adenosine A2; Theophylline; Triazines; Triazoles; Vasoconstriction; Vasodilation | 2006 |
Lack of flow-mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Antibodies, Antinuclear; Arterioles; Blood Pressure; Bradykinin; Disease Models, Animal; Endothelium, Vascular; Female; Hemorheology; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Muscle, Skeletal; Nitroprusside; Serotonin; Vasoconstriction; Vasodilation; Vasodilator Agents | 2006 |
Adenosine restores angiotensin II-induced contractions by receptor-independent enhancement of calcium sensitivity in renal arterioles.
Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Arterioles; Calcium; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Isotonic Contraction; Kidney; Male; Mice; Mice, Inbred C57BL; Myosin Light Chains; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Potassium Chloride; Protein Kinase C; Protein Serine-Threonine Kinases; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; rho-Associated Kinases | 2006 |
Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Cerebrovascular Circulation; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrosation; Peroxynitrous Acid; Reactive Oxygen Species; Superoxides; Tyrosine; Vasodilator Agents; Vibrissae | 2007 |
The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Angiotensin II; Animals; Blood Platelets; Enzyme Activation; Hydrolysis; Hypertension; Male; Phenotype; Phosphoric Diester Hydrolases; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Thymidine Monophosphate; Vasoconstrictor Agents | 2007 |
Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles.
Topics: Adenosine; Angiotensin II; Animals; Arterioles; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Smooth, Vascular; Renal Artery; Vasoconstriction | 2007 |
Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Kidney Cortex; Male; Proteinuria; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Vasoconstrictor Agents | 2008 |
The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Disease Models, Animal; Disease Susceptibility; Estradiol; Estrogen Replacement Therapy; Female; Hypertension; Infusion Pumps, Implantable; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Neocortex; Ovariectomy; Reflex; Sex Factors; Stroke; Time Factors; Vasodilator Agents; Vibrissae | 2008 |
Adenosine increases calcium sensitivity via receptor-independent activation of the p38/MK2 pathway in mesenteric arteries.
Topics: Adenosine; Angiotensin II; Animals; Calcium; Dose-Response Relationship, Drug; Drug Synergism; Male; MAP Kinase Signaling System; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Contraction; Muscle, Smooth, Vascular; Myosin Light Chains; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Purinergic P1; Tissue Culture Techniques; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Effect of adenosine on membrane potential and Ca2+ in juxtaglomerular cells. Comparison with angiotensin II.
Topics: Adenosine; Angiotensin II; Animals; Calcium; Cytosol; Juxtaglomerular Apparatus; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1 | 2008 |
Nitric oxide deficiency and increased adenosine response of afferent arterioles in hydronephrotic mice with hypertension.
Topics: Adenosine; Angiotensin II; Animals; Arterioles; Disease Models, Animal; Enzyme Inhibitors; Hydronephrosis; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Superoxide Dismutase; Superoxide Dismutase-1; Transforming Growth Factors; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Crosstalk between the signaling pathways triggered by angiotensin II and adenosine in the renal proximal tubules: implications for modulation of Na(+)-ATPase activity.
Topics: Adenosine; Angiotensin II; Animals; Cyclic AMP-Dependent Protein Kinases; Kidney Tubules, Proximal; Phosphoinositide Phospholipase C; Protein Kinase C; Receptors, Adenosine A2; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Swine | 2008 |
Role of NOX2 in the regulation of afferent arteriole responsiveness.
Topics: Acetophenones; Adenosine; Angiotensin II; Animals; Arterioles; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypertension; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney Cortex; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Circulation; Superoxides; Vasoconstriction; Vasoconstrictor Agents | 2009 |
Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Calcium; Cytosol; Kidney; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Naphthyridines; Purines; Receptor, Adenosine A1; Receptor, Angiotensin, Type 1; Receptors, Adenosine A2; Triazines; Triazoles; Vasoconstriction | 2009 |
Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Angiotensin II; Animals; Cells, Cultured; Collagen; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Fibroblasts; GTP-Binding Protein alpha Subunits, Gi-Go; Guanine Nucleotide Exchange Factors; Male; Myocardium; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.
Topics: Adenosine; Angiotensin II; Animals; Blood Pressure; Denervation; Ganglionic Blockers; Hindlimb; Hypertension; Kidney; Nitroprusside; Norepinephrine; Pentolinium Tartrate; Rabbits; Regional Blood Flow; Sympathetic Nervous System; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2009 |
Vasopressin is a major vasoconstrictor involved in hindlimb vascular responses to stimulation of adenosine A(1) receptors in the nucleus of the solitary tract.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adrenalectomy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Baroreflex; Blood Pressure; Heart Rate; Hindlimb; Iliac Artery; Losartan; Male; Microinjections; Muscle, Skeletal; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Angiotensin, Type 1; Receptors, Vasopressin; Regional Blood Flow; Solitary Nucleus; Sympathectomy; Time Factors; Vasoconstriction; Vasopressins | 2009 |
A new approach to assessing the structural total peripheral resistance amplifier in renal (Page) hypertension in conscious rabbits.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Blood Vessels; Cellophane; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ganglionic Blockers; Hypertension, Renal; Male; Methoxamine; Rabbits; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2010 |
Adenosine sensitization after angiotensin II stimulation in afferent arterioles from normal rats does not occur during two-kidney, one-clip hypertension.
Topics: Adenosine; Angiotensin II; Animals; Arterioles; Hypertension, Renovascular; In Vitro Techniques; Kidney; Rats; Rats, Wistar; Vasoconstriction | 2011 |
Coordination of fibronectin adhesion with contraction and relaxation in microvascular smooth muscle.
Topics: Adenosine; Angiotensin II; Animals; Cytoskeleton; Elasticity; Fibronectins; Integrins; Microscopy, Atomic Force; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Vascular Stiffness; Vasoconstriction; Vasodilation | 2012 |
[Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
Topics: Adenosine; Angiotensin II; Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Purinergic P1 Receptor Agonists; Random Allocation; Rats; Rats, Sprague-Dawley; Renin | 2012 |
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.
Topics: 5'-Nucleotidase; Adenosine; Adult; Angiotensin II; Animals; Cells, Cultured; Chronic Disease; Endothelial Cells; Endothelin-1; Female; Gene Expression; GPI-Linked Proteins; Humans; Hypertension, Renal; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Receptor, Adenosine A2B; Signal Transduction; Vasoconstrictor Agents | 2013 |
Adenosine inhibits renin release from juxtaglomerular cells via an A1 receptor-TRPC-mediated pathway.
Topics: Adenosine; Angiotensin II; Animals; Female; Juxtaglomerular Apparatus; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A1; Renin; Signal Transduction; Transient Receptor Potential Channels | 2013 |
Gestational modification of murine spiral arteries does not reduce their drug-induced vasoconstrictive responses in vivo.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Endometrium; Female; Male; Mice; Mice, Inbred C57BL; Phenylephrine; Pregnancy; Uterine Artery; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2013 |
Vasoactive agonists exert dynamic and coordinated effects on vascular smooth muscle cell elasticity, cytoskeletal remodelling and adhesion.
Topics: Actins; Adenosine; Angiotensin II; Animals; Biomechanical Phenomena; Cell Adhesion; Cytoskeleton; Elastic Modulus; Elasticity; Microscopy, Atomic Force; Microscopy, Confocal; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents | 2014 |
Adenosine A1 receptor-dependent and independent pathways in modulating renal vascular responses to angiotensin II.
Topics: Adenosine; Angiotensin II; Animals; Kidney; Kidney Glomerulus; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Adenosine A1; Signal Transduction | 2015 |
Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Angiotensin II; Animals; Cytochrome P-450 CYP4A; Endothelium, Vascular; In Vitro Techniques; Male; Mesenteric Arteries; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2B; Receptor, Angiotensin, Type 1; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |
Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adrenergic alpha-1 Receptor Agonists; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Culture Techniques; Dose-Response Relationship, Drug; Fibrosis; Insulin-Like Growth Factor I; Male; Matrix Metalloproteinase 2; Mice; Myocytes, Cardiac; Oxidative Stress; Phenylephrine; Rats; Receptor, Adenosine A1; Up-Regulation | 2016 |
COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
Topics: Adenosine; Angiotensin II; Animals; Cell Line; Connective Tissue Growth Factor; Disease Models, Animal; Drug Evaluation, Preclinical; Fibroblasts; Fibrosis; Humans; Male; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Scleroderma, Systemic; Skin; Transforming Growth Factor beta1 | 2019 |
IMM-H007 improves heart function via reducing cardiac fibrosis.
Topics: Adenosine; AMP-Activated Protein Kinases; Angiotensin II; Animals; Collagen; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart; Humans; Male; Mice; Mice, Inbred C57BL; Myocardium; Myofibroblasts; Phosphorylation; Smad2 Protein; Transforming Growth Factor beta1 | 2019 |
Nitroxide-enhanced MRI of cardiovascular oxidative stress.
Topics: Adenosine; Angiotensin II; Animals; Cardiovascular System; Cyclic N-Oxides; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Myocardial Infarction; Nitrogen Oxides; Obesity; Oxidative Stress; Perfusion; Pyrrolidines | 2020 |
De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Topics: Adenosine; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; E1A-Associated p300 Protein; Gene Expression Regulation; Male; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Signal Transduction; Ubiquitin Thiolesterase; Ubiquitination | 2021 |
CD73 deficiency does not aggravate angiotensin II-induced aortic inflammation in mice.
Topics: 5'-Nucleotidase; Adenosine; Angiotensin II; Animals; Female; Inflammation; Male; Mice; Mice, Knockout | 2023 |